Filing Details
- Accession Number:
- 0001127602-11-008680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-03 15:17:02
- Reporting Period:
- 2011-03-01
- Filing Date:
- 2011-03-03
- Accepted Time:
- 2011-03-03 15:17:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226289 | Eric Craig Schneier | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Evp, Hr, Public Affairs & Comm | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-01 | 6,250 | $49.65 | 23,962 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-03-01 | 6,250 | $68.62 | 17,712 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-03-02 | 4,079 | $70.10 | 13,633 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-03-02 | 3,232 | $70.09 | 10,401 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-03-02 | 200 | $70.44 | 10,201 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-03-01 | 6,250 | $0.00 | 6,250 | $49.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,500 | 2019-02-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 460 | Indirect | By Spouse |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $69.43 (low) and 70.40 (high).
- This represents the weighted average price for shares sold at a range between $69.43 (low) and 70.39 (high).
- This represents the weighted average price for shares sold at a range between $70.43 (low) and $70.44 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon requst by the SEC staff, the issuer, or a security holder of the issuer.
- The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 02/24/09.
Billionaire Hedge Funds
